A DNA Prime and MVA Boost Strategy Provides a Robust Immunity against Infectious Bronchitis Virus in Chickens
Infectious bronchitis (IB) is an acute respiratory disease of chickens caused by the avian coronavirus Infectious Bronchitis Virus (IBV). Modified Live Virus (MLV) vaccines used commercially can revert to virulence in the field, recombine with circulating serotypes, and cause tissue damage in vaccin...
| Main Authors: | , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
MDPI AG
2023-01-01
|
| Series: | Vaccines |
| Subjects: | |
| Online Access: | https://www.mdpi.com/2076-393X/11/2/302 |
| _version_ | 1827755260088680448 |
|---|---|
| author | Shaswath S. Chandrasekar Brock A. Kingstad-Bakke Chia-Wei Wu Yashdeep Phanse Jorge E. Osorio Adel M. Talaat |
| author_facet | Shaswath S. Chandrasekar Brock A. Kingstad-Bakke Chia-Wei Wu Yashdeep Phanse Jorge E. Osorio Adel M. Talaat |
| author_sort | Shaswath S. Chandrasekar |
| collection | DOAJ |
| description | Infectious bronchitis (IB) is an acute respiratory disease of chickens caused by the avian coronavirus Infectious Bronchitis Virus (IBV). Modified Live Virus (MLV) vaccines used commercially can revert to virulence in the field, recombine with circulating serotypes, and cause tissue damage in vaccinated birds. Previously, we showed that a mucosal adjuvant system, QuilA-loaded Chitosan (QAC) nanoparticles encapsulating plasmid vaccine encoding for IBV nucleocapsid (N), is protective against IBV. Herein, we report a heterologous vaccination strategy against IBV, where QAC-encapsulated plasmid immunization is followed by Modified Vaccinia Ankara (MVA) immunization, both expressing the same IBV-N antigen. This strategy led to the initiation of robust T-cell responses. Birds immunized with the heterologous vaccine strategy had reduced clinical severity and >two-fold reduction in viral burden in lachrymal fluid and tracheal swabs post-challenge compared to priming and boosting with the MVA-vectored vaccine alone. The outcomes of this study indicate that the heterologous vaccine platform is more immunogenic and protective than a homologous MVA prime/boost vaccination strategy. |
| first_indexed | 2024-03-11T08:02:48Z |
| format | Article |
| id | doaj.art-60be000bcdc447b28b0113a26f68311b |
| institution | Directory Open Access Journal |
| issn | 2076-393X |
| language | English |
| last_indexed | 2024-03-11T08:02:48Z |
| publishDate | 2023-01-01 |
| publisher | MDPI AG |
| record_format | Article |
| series | Vaccines |
| spelling | doaj.art-60be000bcdc447b28b0113a26f68311b2023-11-16T23:42:31ZengMDPI AGVaccines2076-393X2023-01-0111230210.3390/vaccines11020302A DNA Prime and MVA Boost Strategy Provides a Robust Immunity against Infectious Bronchitis Virus in ChickensShaswath S. Chandrasekar0Brock A. Kingstad-Bakke1Chia-Wei Wu2Yashdeep Phanse3Jorge E. Osorio4Adel M. Talaat5Department of Pathobiological Sciences, School of Veterinary Medicine, University of Wisconsin, Madison, WI 53706, USADepartment of Pathobiological Sciences, School of Veterinary Medicine, University of Wisconsin, Madison, WI 53706, USADepartment of Pathobiological Sciences, School of Veterinary Medicine, University of Wisconsin, Madison, WI 53706, USAPan Genome Systems, Madison, WI 53719, USADepartment of Pathobiological Sciences, School of Veterinary Medicine, University of Wisconsin, Madison, WI 53706, USADepartment of Pathobiological Sciences, School of Veterinary Medicine, University of Wisconsin, Madison, WI 53706, USAInfectious bronchitis (IB) is an acute respiratory disease of chickens caused by the avian coronavirus Infectious Bronchitis Virus (IBV). Modified Live Virus (MLV) vaccines used commercially can revert to virulence in the field, recombine with circulating serotypes, and cause tissue damage in vaccinated birds. Previously, we showed that a mucosal adjuvant system, QuilA-loaded Chitosan (QAC) nanoparticles encapsulating plasmid vaccine encoding for IBV nucleocapsid (N), is protective against IBV. Herein, we report a heterologous vaccination strategy against IBV, where QAC-encapsulated plasmid immunization is followed by Modified Vaccinia Ankara (MVA) immunization, both expressing the same IBV-N antigen. This strategy led to the initiation of robust T-cell responses. Birds immunized with the heterologous vaccine strategy had reduced clinical severity and >two-fold reduction in viral burden in lachrymal fluid and tracheal swabs post-challenge compared to priming and boosting with the MVA-vectored vaccine alone. The outcomes of this study indicate that the heterologous vaccine platform is more immunogenic and protective than a homologous MVA prime/boost vaccination strategy.https://www.mdpi.com/2076-393X/11/2/302IBVnanovaccineintranasal vaccineheterologous vaccine |
| spellingShingle | Shaswath S. Chandrasekar Brock A. Kingstad-Bakke Chia-Wei Wu Yashdeep Phanse Jorge E. Osorio Adel M. Talaat A DNA Prime and MVA Boost Strategy Provides a Robust Immunity against Infectious Bronchitis Virus in Chickens Vaccines IBV nanovaccine intranasal vaccine heterologous vaccine |
| title | A DNA Prime and MVA Boost Strategy Provides a Robust Immunity against Infectious Bronchitis Virus in Chickens |
| title_full | A DNA Prime and MVA Boost Strategy Provides a Robust Immunity against Infectious Bronchitis Virus in Chickens |
| title_fullStr | A DNA Prime and MVA Boost Strategy Provides a Robust Immunity against Infectious Bronchitis Virus in Chickens |
| title_full_unstemmed | A DNA Prime and MVA Boost Strategy Provides a Robust Immunity against Infectious Bronchitis Virus in Chickens |
| title_short | A DNA Prime and MVA Boost Strategy Provides a Robust Immunity against Infectious Bronchitis Virus in Chickens |
| title_sort | dna prime and mva boost strategy provides a robust immunity against infectious bronchitis virus in chickens |
| topic | IBV nanovaccine intranasal vaccine heterologous vaccine |
| url | https://www.mdpi.com/2076-393X/11/2/302 |
| work_keys_str_mv | AT shaswathschandrasekar adnaprimeandmvabooststrategyprovidesarobustimmunityagainstinfectiousbronchitisvirusinchickens AT brockakingstadbakke adnaprimeandmvabooststrategyprovidesarobustimmunityagainstinfectiousbronchitisvirusinchickens AT chiaweiwu adnaprimeandmvabooststrategyprovidesarobustimmunityagainstinfectiousbronchitisvirusinchickens AT yashdeepphanse adnaprimeandmvabooststrategyprovidesarobustimmunityagainstinfectiousbronchitisvirusinchickens AT jorgeeosorio adnaprimeandmvabooststrategyprovidesarobustimmunityagainstinfectiousbronchitisvirusinchickens AT adelmtalaat adnaprimeandmvabooststrategyprovidesarobustimmunityagainstinfectiousbronchitisvirusinchickens AT shaswathschandrasekar dnaprimeandmvabooststrategyprovidesarobustimmunityagainstinfectiousbronchitisvirusinchickens AT brockakingstadbakke dnaprimeandmvabooststrategyprovidesarobustimmunityagainstinfectiousbronchitisvirusinchickens AT chiaweiwu dnaprimeandmvabooststrategyprovidesarobustimmunityagainstinfectiousbronchitisvirusinchickens AT yashdeepphanse dnaprimeandmvabooststrategyprovidesarobustimmunityagainstinfectiousbronchitisvirusinchickens AT jorgeeosorio dnaprimeandmvabooststrategyprovidesarobustimmunityagainstinfectiousbronchitisvirusinchickens AT adelmtalaat dnaprimeandmvabooststrategyprovidesarobustimmunityagainstinfectiousbronchitisvirusinchickens |